Literature DB >> 24396032

Targeted radionuclide therapy: proceedings of a joint workshop hosted by the National Cancer Institute and the Society of Nuclear Medicine and Molecular Imaging.

Frederic Fahey1, Katherine Zukotynski, Jacek Capala, Nancy Knight.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24396032     DOI： 10.2967/jnumed.113.135178

Source DB:  PubMed          Journal:  J Nucl Med        ISSN： 0161-5505            Impact factor:   10.057


× No keyword cloud information.
  9 in total

Review 1.  Future cancer research priorities in the USA: a Lancet Oncology Commission.

Authors:  Elizabeth M Jaffee; Chi Van Dang; David B Agus; Brian M Alexander; Kenneth C Anderson; Alan Ashworth; Anna D Barker; Roshan Bastani; Sangeeta Bhatia; Jeffrey A Bluestone; Otis Brawley; Atul J Butte; Daniel G Coit; Nancy E Davidson; Mark Davis; Ronald A DePinho; Robert B Diasio; Giulio Draetta; A Lindsay Frazier; Andrew Futreal; Sam S Gambhir; Patricia A Ganz; Levi Garraway; Stanton Gerson; Sumit Gupta; James Heath; Ruth I Hoffman; Cliff Hudis; Chanita Hughes-Halbert; Ramy Ibrahim; Hossein Jadvar; Brian Kavanagh; Rick Kittles; Quynh-Thu Le; Scott M Lippman; David Mankoff; Elaine R Mardis; Deborah K Mayer; Kelly McMasters; Neal J Meropol; Beverly Mitchell; Peter Naredi; Dean Ornish; Timothy M Pawlik; Jeffrey Peppercorn; Martin G Pomper; Derek Raghavan; Christine Ritchie; Sally W Schwarz; Richard Sullivan; Richard Wahl; Jedd D Wolchok; Sandra L Wong; Alfred Yung
Journal:  Lancet Oncol       Date:  2017-10-31       Impact factor: 41.316

2.  One-Year Postapproval Clinical Experience with Radium-223 Dichloride in Patients with Metastatic Castrate-Resistant Prostate Cancer.

Authors:  Hossein Jadvar; Sudha Challa; David I Quinn; Peter S Conti
Journal:  Cancer Biother Radiopharm       Date:  2015-03-06       Impact factor: 3.099

3.  Targeting angiogenesis for radioimmunotherapy with a 177Lu-labeled antibody.

Authors:  Emily B Ehlerding; Saige Lacognata; Dawei Jiang; Carolina A Ferreira; Shreya Goel; Reinier Hernandez; Justin J Jeffery; Charles P Theuer; Weibo Cai
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-08-18       Impact factor: 9.236

Review 4.  Targeted Radionuclide Therapy: An Evolution Toward Precision Cancer Treatment.

Authors:  Hossein Jadvar
Journal:  AJR Am J Roentgenol       Date:  2017-05-02       Impact factor: 3.959

5.  Beta emitters rhenium-188 and lutetium-177 are equally effective in radioimmunotherapy of HPV-positive experimental cervical cancer.

Authors:  Rebecca Phaeton; Zewei Jiang; Ekaterina Revskaya; Darrell R Fisher; Gary L Goldberg; Ekaterina Dadachova
Journal:  Cancer Med       Date:  2015-12-02       Impact factor: 4.452

6.  Deep-dose: a voxel dose estimation method using deep convolutional neural network for personalized internal dosimetry.

Authors:  Min Sun Lee; Donghwi Hwang; Joong Hyun Kim; Jae Sung Lee
Journal:  Sci Rep       Date:  2019-07-16       Impact factor: 4.379

Review 7.  Targeted Radionuclide Therapy: Practical Applications and Future Prospects.

Authors:  Katherine Zukotynski; Hossein Jadvar; Jacek Capala; Frederic Fahey
Journal:  Biomark Cancer       Date:  2016-05-18

8.  Realising the potential of radioligand therapy: policy solutions for the barriers to implementation across Europe.

Authors:  C Merkel; C H Whicher; J Bomanji; K Herrmann; J Ćwikła; N Jervis; S Wait; A Chiti
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-06       Impact factor: 9.236

9.  Biodistribution and internal radiation dosimetry of a companion diagnostic radiopharmaceutical, [68Ga]PSMA-11, in subcutaneous prostate cancer xenograft model mice.

Authors:  Su Bin Kim; In Ho Song; Yoo Sung Song; Byung Chul Lee; Arun Gupta; Jae Sung Lee; Hyun Soo Park; Sang Eun Kim
Journal:  Sci Rep       Date:  2021-07-27       Impact factor: 4.379
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.